Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.
Regel Therapeutics has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in September 2023.
Regel Therapeutics's investors include HS Chau Foundation.
Regel Therapeutics is headquartered in Boston, United States.
Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.
Regel Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Regel Therapeutics — Funding & Investors." VCBacked, September 29, 2023, https://www.vcbacked.co/company/regel-therapeutics. Accessed October 1, 2026.
VCBacked. (2023). Regel Therapeutics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/regel-therapeutics
{{cite web |title=Regel Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/regel-therapeutics |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated